First human tests begin for experimental obesity medication
NCT ID NCT07170319
Summary
This early-stage study is testing the safety of a new drug called IBI3032 in people who are overweight or have obesity. Researchers will give 79 participants multiple doses over 4 weeks to check for side effects and see how the body processes the medication. The main goal is to determine if the drug is safe enough for further testing, not to measure weight loss results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Frist Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.